Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar russiangambit (29.88) Submitted: 2/6/2011 4:17:47 PM : Outperform Start Price: $9.63 SVNT Score: -91.58

short squeeze ahoy

Featured Broker Partners


Advertisement